Patent details

LUC00183 Product Name: ozanimod, ou un sel pharmaceutiquement acceptable de celui-ci, y compris le sel chlorhydrate

Basic Information

Publication number:
LUC00183
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP181793019
Legal Status:
Invalid
Application number:
LUC00183
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1442/001-003
Marketing Authorization Type:
Marketing Authorization Date:
25/05/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
17/11/2020
First Marketing Authorization date:
25/05/2020
Grant date:
01/07/2024
Activation date:
Publication date:
17/11/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/12/2034
SPC Extension Expiration:
21/12/2034
Rejection date:
Withdrawal date:

Owner

From:
17/11/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/11/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/13
Publication date:
07/12/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2024/10
Publication date:
06/08/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
VRV
Bulletin edition number:
2025/02
Publication date:
06/02/2025
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
17/11/2020 Application Form 4
17/11/2020 Outgoing Correspondence 1
17/11/2020 MA publication 4
17/11/2020 Summary of the product caracteristics 43
17/11/2020 Marketing authorization 3
17/11/2020 Publication 1
01/07/2024 Publication 1
01/07/2024 Certificate 1
08/07/2024 Outgoing Correspondence 1